SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001104659-17-041853
Filing Date
2017-06-27
Accepted
2017-06-27 17:21:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A a17-15001_3sctota.htm SC TO-T/A 54089
  Complete submission text file 0001104659-17-041853.txt   55697
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-89113 | Film No.: 17933171
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 6108166640
Nabriva Therapeutics Plc (Filed by) CIK: 0001703287 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations